FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
SAGE Therapeutics (NASDAQ: SAGE) reported Q1 EPS of ($3.37), $0.12 worse than the analyst estimate of ($3.25).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
... More
